The drug for the coronavirus "Mir-19" is approved for use by citizens from 18 to 65 years old

"Indication for use: treatment of a new coronavirus infection (COVID-19) in adults aged 18 to 65," TASS quotes the text of the document.

The Russian Ministry of Health previously registered the domestic drug MIR 19, intended for the treatment of the SARS-CoV-2 coronavirus.

As the developers of the drug emphasize, it is universal against all known variants of SARS-CoV-2, including the omicron strain.

The medicine will be used in hospitals in the form of inhalation - during tests in the "red zone" MIR 19 has shown its effectiveness in comparison with standard therapy.